Countries China
KeChow Pharma's Tunlametinib Receives Historic Approval in China for Advanced Melanoma Treatment
KeChow Pharma, a commercial-stage pharmaceutical company focused on developing and commercializing differentiated small molecule therapeutics for cancer, t...
March 19, 2024 | News
CStone's Sugemalimab Granted Historic Approval in China for Gastric Cancer Treatment
CStone Pharmaceuticals has achieved a significant milestone with the approval of sugemalimab (Cejemly®) by the National Medical Products Administration...
March 18, 2024 | News
Sanyou Biopharmaceuticals Launches Groundbreaking Intelligent Innovative Biologics R&D Service Platform
Sanyou Biopharmaceutical Co., Ltd. is delighted to announce the official launch of the "Sanyou Intelligent Innovative Biologics R&D Service Platform," ...
March 13, 2024 | News
FDA Grants Nefecon® Orphan Drug Exclusivity for Seven Years
Everest Medicines licensing partner Calliditas Therapeutics AB announced that the U.S. FDA has granted an orphan drug exclusivity period of seven yea...
March 12, 2024 | News
TransThera Launches Global Phase 3 Trial for Cholangiocarcinoma in EU, Receives Orphan Drug Status for Tinengotinib from EMA
TransThera, a clinical-stage biopharmaceutical company dedicated to innovating differentiated drugs globally, today announced that the randomized, controll...
March 11, 2024 | News
Genesis MedTech and Silk Road Medical Partner to Treat Carotid Artery Disease in China
Since its establishment in 2019, Genesis MedTech Group has continuously strived to enhance its peripheral interventional portfolio, offering compre...
March 11, 2024 | News
Zylox-Tonbridge Forms Strategic Partnership with Avinger to Revolutionize Vascular Disease Treatment in Greater China
This partnership includes an exclusive right to Zylox-Tonbridge to localize, manufacture, and commercialize the entire product family developed by Avinger ...
March 08, 2024 | News
Innovent Biologics and AnHeart Therapeutics Secure Second NDA Acceptance for Groundbreaking Lung Cancer Treatment in China
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality me...
March 06, 2024 | News
WuXi Biologics attains leadership status in 2023 CDP Climate Change evaluation
CDP runs the global disclosure system for investors, companies, cities, states and regions to manage their environmental impact. In 2023, more than...
March 06, 2024 | News
YolTech's Gene Editing Therapy YOLT-201 Advances to Phase I Clinical Trials for Rare Genetic Disease
YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced the Center for Drug Evaluation ...
March 05, 2024 | News
Teva Partners with Jiangsu Nhwa to Enhance AUSTEDO® Access in China
“Nhwa has deep neuro-psychiatry expertise and capabilities, from research and development to commercialization,” commented Theodor Wee,...
February 28, 2024 | News
Everest Medicines, Kezar Get China NMPA Nod for Lupus Nephritis Trial
Everest Medicines (HKEX 1952.HK) and Kezar Life Sciences, Inc. (Nasdaq: KZR) announced that the Center for Drug Evaluation (CDE) of China's Natio...
February 27, 2024 | News
Enveric Biosciences Divests Cancer-Targeting Cannabinoid IP to Focus on Mental Health Therapeutics
Enveric Biosciences (NASDAQ: ENVB), a pioneering biotechnology firm at the forefront of developing neuroplastogenic small-molecule therapeutics, an...
February 26, 2024 | News
Immunofoco Achieves Historic Dual IND Approval for Groundbreaking EpCAM CAR-T Therapy
EpCAM, known for its presence in circulating tumor cells (CTCs) and high expression in primary and metastatic lesions of gastrointestinal tumors, r...
February 26, 2024 | News
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
